QR Kod

Changing incentives to ACCELERATE drug development for paediatric cancer

Abstract Background More effective incentives are needed to motivate paediatric oncology drug development, uncoupling it from dependency on adult drug development. Although the current European and North‐American legislations aim to promote drug development for paediatrics and rare diseases, childre...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Teresa deRojas, Pamela Kearns, Patricia Blanc, Jeffrey Skolnik, Elizabeth Fox, Leona Knox, Raphael Rousseau, François Doz, Nick Bird, Andrew J. Pearson, Gilles Vassal
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wiley 2023-04-01
Seri Bilgileri:Cancer Medicine
Konular:
drug development
incentives
paediatric oncology
paediatric regulation
supplementary protection certificate
Online Erişim:https://doi.org/10.1002/cam4.5627
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller